Sagamihara, Japan

Ippei Kuwahara

This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignee: Teijin Pharma Limited. Active years: 2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ippei Kuwahara. Retrieved from https://idiyas.com/inventor/ippei-kuwahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2017

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ippei Kuwahara

Introduction

Ippei Kuwahara is a notable inventor based in Sagamihara, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of therapeutic drugs for hypertension. His work is characterized by a commitment to improving health outcomes through innovative solutions.

Latest Patents

Kuwahara holds a patent for a therapeutic drug aimed at treating hypertension or prehypertension. The patent describes a therapeutic or preventive drug that includes specific active ingredients designed to effectively manage high-normal blood pressure. This invention not only addresses the treatment of hypertension but also outlines a method for its prevention.

Career Highlights

Ippei Kuwahara is associated with Teijin Pharma Limited, a company known for its advancements in healthcare and pharmaceuticals. His role at the company has allowed him to focus on research and development, contributing to the creation of effective medical solutions.

Collaborations

Kuwahara has worked alongside talented colleagues such as Mizuho Tamura and Yoshimasa Takahashi. Their collaborative efforts have fostered an environment of innovation and creativity within their projects.

Conclusion

Ippei Kuwahara's contributions to the field of hypertension treatment exemplify the impact of dedicated inventors in healthcare. His innovative approach continues to pave the way for advancements in medical therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…